https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Adjuvant systemic treatment of premenopausal women with hormone receptor-positive early breast cancer: lights and shadows https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34779 Thu 31 Oct 2019 16:13:17 AEDT ]]> Adjuvant ovarian function suppression and cognitive function in women with breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24211 Sat 24 Mar 2018 07:12:41 AEDT ]]> Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): the SOFT-EST substudy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23759 Sat 24 Mar 2018 07:11:09 AEDT ]]>